Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingersoll Rand (IR) Accumulated Expenses (2016 - 2025)

Ingersoll Rand's Accumulated Expenses history spans 10 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 9.94% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 9.94%, while the annual FY2025 figure was $1.1 billion, 9.94% up from the prior year.
  • Accumulated Expenses reached $1.1 billion in Q4 2025 per IR's latest filing, down from $1.1 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.1 billion in Q3 2025 to a low of $42.5 million in Q4 2021.
  • Average Accumulated Expenses over 5 years is $894.4 million, with a median of $965.0 million recorded in 2023.
  • The largest YoY upside for Accumulated Expenses was 2557.75% in 2021 against a maximum downside of 94.0% in 2021.
  • A 5-year view of Accumulated Expenses shows it stood at $42.5 million in 2021, then skyrocketed by 1920.71% to $858.8 million in 2022, then increased by 15.92% to $995.5 million in 2023, then dropped by 2.34% to $972.2 million in 2024, then rose by 9.94% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for IR's Accumulated Expenses are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $997.6 million (Q2 2025).